Will The Rising Tide Of Rx Omega-3s Float The Fish Oil Supplement Market?
This article was originally published in The Pink Sheet Daily
Executive Summary
Nutritional industry stakeholders say the jury is still out on how omega-3 pharmaceuticals will affect the supplement space long-term, but supplement marketers should do everything they can to step up their game.
You may also be interested in...
Amarin's Omega-3 Fair Trade Complaint Questions US Dietary Ingredient Standards
Amarin's recent fair trade complaint targetting purified EPA dietary supplements and formulations also raises broader questions about using synthetic dietary ingredients in consumer supplements and the extent to which a substance’s identification in an IND precludes subsequent use as a dietary ingredient.
Amarin's Omega-3 Fair Trade Complaint Questions US Dietary Ingredient Standards
Amarin's recent fair trade complaint targetting purified EPA dietary supplements and formulations also raises broader questions about using synthetic dietary ingredients in consumer supplements and the extent to which a substance’s identification in an IND precludes subsequent use as a dietary ingredient.
Omega-3 Drug Firm’s Trade Complaint Questions US Dietary Ingredient Standards
Amarin targets purified EPA dietary supplements or formulations containing primarily EPA in ethyl ester or re-esterified form and raises general questions about using synthetic dietary ingredients in supplements and about the extent to which a substance’s previous identification as an IND candidate precludes its subsequent use as a dietary ingredient.